Overview Financials News + Filings Key Docs Charts Ownership Insiders |
CANNAPHARMARX, INC. (CPMD)
|
Add to portfolio |
|
|
Price: |
$0.02
| | Metrics |
OS: |
257.6
|
M
| |
|
|
Market cap: |
$4.64
|
M
| |
|
|
Net debt:
|
$1.15
|
M
| |
|
|
EV:
|
$5.78
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | -6.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Revenue growth | | | | | | | -100.0% | |
Cost of goods sold | -6.7 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 11.7 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | -11.7 | 0.0 |
Gross margin | 0.0% | | | | | | | 89.9% |
Selling, general and administrative | | | | 0.3 | | | | 1.0 |
General and administrative | 2.1 | 3.1 | 1.1 | 0.0 | 0.0 | 0.3 | 4.2 | 0.8 |
EBITA | -2.6 | -4.5 | -9.9 | -0.9 | 0.0 | -1.0 | -11.7 | -2.0 |
EBITA margin | 39.2% | | | | | | | -5811.5% |
Amortization of intangibles | | 0.1 | 0.1 | | | | | |
EBIT | -2.6 | -4.6 | -10.1 | -0.9 | 0.0 | -1.0 | -11.7 | -2.0 |
EBIT margin | 39.2% | | | | | | | -5811.5% |
Pre-tax income | -8.8 | -19.9 | -20.5 | -3.1 | 0.0 | -1.0 | -11.7 | -4.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -8.8 | -19.9 | -20.5 | -3.1 | 0.0 | -1.0 | -11.7 | -4.0 |
Net margin | 132.4% | | | | | | | -11428.7% |
|
Diluted EPS | ($0.12) | ($0.49) | ($0.66) | ($0.17) | $0.00 | ($0.06) | ($0.77) | ($0.36) |
Shares outstanding (diluted) | 74.7 | 40.7 | 31.2 | 18.0 | 18.0 | 18.0 | 15.3 | 11.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|